- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Newcastle Disease Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Newcastle Disease Vaccine market size is estimated to be worth US$ 323.9 million in 2021 and is forecast to a readjusted size of USD 402.7 million by 2028 with a CAGR of 3.2% during review period. Chicken accounting for % of the Newcastle Disease Vaccine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Live Vaccines segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Newcastle Disease Vaccine include Merial, CEVA, QYH Biotech, Ringpu Biology, and Yebio, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Newcastle Disease Vaccine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Live Vaccines
Killed Vaccines
Market segment by Application can be divided into
Chicken
Duck & Goose
Other
The key market players for global Newcastle Disease Vaccine market are listed below:
Merial
CEVA
QYH Biotech
Ringpu Biology
Yebio
Harbin Veterinary Research Institute
Merck Animal Health
DHN
Zoetis
ChengDu Tecbond
Elanco (Lohmann)
FATRO
CAVAC
Vaksindo
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Newcastle Disease Vaccine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Newcastle Disease Vaccine, with price, sales, revenue and global market share of Newcastle Disease Vaccine from 2019 to 2022.
Chapter 3, the Newcastle Disease Vaccine competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Newcastle Disease Vaccine breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Newcastle Disease Vaccine market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Newcastle Disease Vaccine.
Chapter 13, 14, and 15, to describe Newcastle Disease Vaccine sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Newcastle Disease Vaccine Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Newcastle Disease Vaccine Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Live Vaccines
1.2.3 Killed Vaccines
1.3 Market Analysis by Application
1.3.1 Overview: Global Newcastle Disease Vaccine Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Chicken
1.3.3 Duck & Goose
1.3.4 Other
1.4 Global Newcastle Disease Vaccine Market Size & Forecast
1.4.1 Global Newcastle Disease Vaccine Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Newcastle Disease Vaccine Sales in Volume (2017-2028)
1.4.3 Global Newcastle Disease Vaccine Price (2017-2028)
1.5 Global Newcastle Disease Vaccine Production Capacity Analysis
1.5.1 Global Newcastle Disease Vaccine Total Production Capacity (2017-2028)
1.5.2 Global Newcastle Disease Vaccine Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Newcastle Disease Vaccine Market Drivers
1.6.2 Newcastle Disease Vaccine Market Restraints
1.6.3 Newcastle Disease Vaccine Trends Analysis
2 Manufacturers Profiles
2.1 Merial
2.1.1 Merial Details
2.1.2 Merial Major Business
2.1.3 Merial Newcastle Disease Vaccine Product and Services
2.1.4 Merial Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 CEVA
2.2.1 CEVA Details
2.2.2 CEVA Major Business
2.2.3 CEVA Newcastle Disease Vaccine Product and Services
2.2.4 CEVA Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 QYH Biotech
2.3.1 QYH Biotech Details
2.3.2 QYH Biotech Major Business
2.3.3 QYH Biotech Newcastle Disease Vaccine Product and Services
2.3.4 QYH Biotech Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Ringpu Biology
2.4.1 Ringpu Biology Details
2.4.2 Ringpu Biology Major Business
2.4.3 Ringpu Biology Newcastle Disease Vaccine Product and Services
2.4.4 Ringpu Biology Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Yebio
2.5.1 Yebio Details
2.5.2 Yebio Major Business
2.5.3 Yebio Newcastle Disease Vaccine Product and Services
2.5.4 Yebio Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Harbin Veterinary Research Institute
2.6.1 Harbin Veterinary Research Institute Details
2.6.2 Harbin Veterinary Research Institute Major Business
2.6.3 Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
2.6.4 Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Merck Animal Health
2.7.1 Merck Animal Health Details
2.7.2 Merck Animal Health Major Business
2.7.3 Merck Animal Health Newcastle Disease Vaccine Product and Services
2.7.4 Merck Animal Health Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 DHN
2.8.1 DHN Details
2.8.2 DHN Major Business
2.8.3 DHN Newcastle Disease Vaccine Product and Services
2.8.4 DHN Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Zoetis
2.9.1 Zoetis Details
2.9.2 Zoetis Major Business
2.9.3 Zoetis Newcastle Disease Vaccine Product and Services
2.9.4 Zoetis Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 ChengDu Tecbond
2.10.1 ChengDu Tecbond Details
2.10.2 ChengDu Tecbond Major Business
2.10.3 ChengDu Tecbond Newcastle Disease Vaccine Product and Services
2.10.4 ChengDu Tecbond Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11 Elanco (Lohmann)
2.11.1 Elanco (Lohmann) Details
2.11.2 Elanco (Lohmann) Major Business
2.11.3 Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
2.11.4 Elanco (Lohmann) Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12 FATRO
2.12.1 FATRO Details
2.12.2 FATRO Major Business
2.12.3 FATRO Newcastle Disease Vaccine Product and Services
2.12.4 FATRO Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13 CAVAC
2.13.1 CAVAC Details
2.13.2 CAVAC Major Business
2.13.3 CAVAC Newcastle Disease Vaccine Product and Services
2.13.4 CAVAC Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14 Vaksindo
2.14.1 Vaksindo Details
2.14.2 Vaksindo Major Business
2.14.3 Vaksindo Newcastle Disease Vaccine Product and Services
2.14.4 Vaksindo Newcastle Disease Vaccine Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Newcastle Disease Vaccine Breakdown Data by Manufacturer
3.1 Global Newcastle Disease Vaccine Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Newcastle Disease Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Newcastle Disease Vaccine
3.4 Market Concentration Rate
3.4.1 Top 3 Newcastle Disease Vaccine Manufacturer Market Share in 2021
3.4.2 Top 6 Newcastle Disease Vaccine Manufacturer Market Share in 2021
3.5 Global Newcastle Disease Vaccine Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Newcastle Disease Vaccine Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Newcastle Disease Vaccine Market Size by Region
4.1.1 Global Newcastle Disease Vaccine Sales in Volume by Region (2017-2028)
4.1.2 Global Newcastle Disease Vaccine Revenue by Region (2017-2028)
4.2 North America Newcastle Disease Vaccine Revenue (2017-2028)
4.3 Europe Newcastle Disease Vaccine Revenue (2017-2028)
4.4 Asia-Pacific Newcastle Disease Vaccine Revenue (2017-2028)
4.5 South America Newcastle Disease Vaccine Revenue (2017-2028)
4.6 Middle East and Africa Newcastle Disease Vaccine Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Newcastle Disease Vaccine Sales in Volume by Type (2017-2028)
5.2 Global Newcastle Disease Vaccine Revenue by Type (2017-2028)
5.3 Global Newcastle Disease Vaccine Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Newcastle Disease Vaccine Sales in Volume by Application (2017-2028)
6.2 Global Newcastle Disease Vaccine Revenue by Application (2017-2028)
6.3 Global Newcastle Disease Vaccine Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Newcastle Disease Vaccine Sales by Type (2017-2028)
7.2 North America Newcastle Disease Vaccine Sales by Application (2017-2028)
7.3 North America Newcastle Disease Vaccine Market Size by Country
7.3.1 North America Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
7.3.2 North America Newcastle Disease Vaccine Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Newcastle Disease Vaccine Sales by Type (2017-2028)
8.2 Europe Newcastle Disease Vaccine Sales by Application (2017-2028)
8.3 Europe Newcastle Disease Vaccine Market Size by Country
8.3.1 Europe Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
8.3.2 Europe Newcastle Disease Vaccine Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Newcastle Disease Vaccine Sales by Type (2017-2028)
9.2 Asia-Pacific Newcastle Disease Vaccine Sales by Application (2017-2028)
9.3 Asia-Pacific Newcastle Disease Vaccine Market Size by Region
9.3.1 Asia-Pacific Newcastle Disease Vaccine Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Newcastle Disease Vaccine Sales by Type (2017-2028)
10.2 South America Newcastle Disease Vaccine Sales by Application (2017-2028)
10.3 South America Newcastle Disease Vaccine Market Size by Country
10.3.1 South America Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
10.3.2 South America Newcastle Disease Vaccine Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Newcastle Disease Vaccine Sales by Type (2017-2028)
11.2 Middle East & Africa Newcastle Disease Vaccine Sales by Application (2017-2028)
11.3 Middle East & Africa Newcastle Disease Vaccine Market Size by Country
11.3.1 Middle East & Africa Newcastle Disease Vaccine Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Newcastle Disease Vaccine Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Newcastle Disease Vaccine and Key Manufacturers
12.2 Manufacturing Costs Percentage of Newcastle Disease Vaccine
12.3 Newcastle Disease Vaccine Production Process
12.4 Newcastle Disease Vaccine Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Newcastle Disease Vaccine Typical Distributors
13.3 Newcastle Disease Vaccine Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer
List of Tables
Table 1. Global Newcastle Disease Vaccine Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Newcastle Disease Vaccine Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Merial Basic Information, Manufacturing Base and Competitors
Table 4. Merial Major Business
Table 5. Merial Newcastle Disease Vaccine Product and Services
Table 6. Merial Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. CEVA Basic Information, Manufacturing Base and Competitors
Table 8. CEVA Major Business
Table 9. CEVA Newcastle Disease Vaccine Product and Services
Table 10. CEVA Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. QYH Biotech Basic Information, Manufacturing Base and Competitors
Table 12. QYH Biotech Major Business
Table 13. QYH Biotech Newcastle Disease Vaccine Product and Services
Table 14. QYH Biotech Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 16. Ringpu Biology Major Business
Table 17. Ringpu Biology Newcastle Disease Vaccine Product and Services
Table 18. Ringpu Biology Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Yebio Basic Information, Manufacturing Base and Competitors
Table 20. Yebio Major Business
Table 21. Yebio Newcastle Disease Vaccine Product and Services
Table 22. Yebio Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Harbin Veterinary Research Institute Basic Information, Manufacturing Base and Competitors
Table 24. Harbin Veterinary Research Institute Major Business
Table 25. Harbin Veterinary Research Institute Newcastle Disease Vaccine Product and Services
Table 26. Harbin Veterinary Research Institute Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Merck Animal Health Basic Information, Manufacturing Base and Competitors
Table 28. Merck Animal Health Major Business
Table 29. Merck Animal Health Newcastle Disease Vaccine Product and Services
Table 30. Merck Animal Health Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. DHN Basic Information, Manufacturing Base and Competitors
Table 32. DHN Major Business
Table 33. DHN Newcastle Disease Vaccine Product and Services
Table 34. DHN Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Zoetis Basic Information, Manufacturing Base and Competitors
Table 36. Zoetis Major Business
Table 37. Zoetis Newcastle Disease Vaccine Product and Services
Table 38. Zoetis Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 40. ChengDu Tecbond Major Business
Table 41. ChengDu Tecbond Newcastle Disease Vaccine Product and Services
Table 42. ChengDu Tecbond Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Elanco (Lohmann) Basic Information, Manufacturing Base and Competitors
Table 44. Elanco (Lohmann) Major Business
Table 45. Elanco (Lohmann) Newcastle Disease Vaccine Product and Services
Table 46. Elanco (Lohmann) Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 47. FATRO Basic Information, Manufacturing Base and Competitors
Table 48. FATRO Major Business
Table 49. FATRO Newcastle Disease Vaccine Product and Services
Table 50. FATRO Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 51. CAVAC Basic Information, Manufacturing Base and Competitors
Table 52. CAVAC Major Business
Table 53. CAVAC Newcastle Disease Vaccine Product and Services
Table 54. CAVAC Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 55. Vaksindo Basic Information, Manufacturing Base and Competitors
Table 56. Vaksindo Major Business
Table 57. Vaksindo Newcastle Disease Vaccine Product and Services
Table 58. Vaksindo Newcastle Disease Vaccine Sales (M Doses), Price (USD/K Doses), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 59. Global Newcastle Disease Vaccine Sales by Manufacturer (2019, 2020, 2021, and 2022) & (M Doses)
Table 60. Global Newcastle Disease Vaccine Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 61. Market Position of Manufacturers in Newcastle Disease Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 62. Global Newcastle Disease Vaccine Production Capacity by Company, (M Doses): 2020 VS 2021
Table 63. Head Office and Newcastle Disease Vaccine Production Site of Key Manufacturer
Table 64. Newcastle Disease Vaccine New Entrant and Capacity Expansion Plans
Table 65. Newcastle Disease Vaccine Mergers & Acquisitions in the Past Five Years
Table 66. Global Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
Table 67. Global Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
Table 68. Global Newcastle Disease Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 69. Global Newcastle Disease Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 70. Global Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 71. Global Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 72. Global Newcastle Disease Vaccine Revenue by Type (2017-2022) & (USD Million)
Table 73. Global Newcastle Disease Vaccine Revenue by Type (2023-2028) & (USD Million)
Table 74. Global Newcastle Disease Vaccine Price by Type (2017-2022) & (USD/K Doses)
Table 75. Global Newcastle Disease Vaccine Price by Type (2023-2028) & (USD/K Doses)
Table 76. Global Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 77. Global Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 78. Global Newcastle Disease Vaccine Revenue by Application (2017-2022) & (USD Million)
Table 79. Global Newcastle Disease Vaccine Revenue by Application (2023-2028) & (USD Million)
Table 80. Global Newcastle Disease Vaccine Price by Application (2017-2022) & (USD/K Doses)
Table 81. Global Newcastle Disease Vaccine Price by Application (2023-2028) & (USD/K Doses)
Table 82. North America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 83. North America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 84. North America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 85. North America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 86. North America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 87. North America Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 88. North America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 89. North America Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 90. Europe Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 91. Europe Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 92. Europe Newcastle Disease Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 93. Europe Newcastle Disease Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 94. Europe Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 95. Europe Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 96. Europe Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 97. Europe Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 98. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
Table 99. Asia-Pacific Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
Table 100. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 101. Asia-Pacific Newcastle Disease Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 102. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 103. Asia-Pacific Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 104. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 105. Asia-Pacific Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 106. South America Newcastle Disease Vaccine Sales by Country (2017-2022) & (M Doses)
Table 107. South America Newcastle Disease Vaccine Sales by Country (2023-2028) & (M Doses)
Table 108. South America Newcastle Disease Vaccine Revenue by Country (2017-2022) & (USD Million)
Table 109. South America Newcastle Disease Vaccine Revenue by Country (2023-2028) & (USD Million)
Table 110. South America Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 111. South America Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 112. South America Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 113. South America Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 114. Middle East & Africa Newcastle Disease Vaccine Sales by Region (2017-2022) & (M Doses)
Table 115. Middle East & Africa Newcastle Disease Vaccine Sales by Region (2023-2028) & (M Doses)
Table 116. Middle East & Africa Newcastle Disease Vaccine Revenue by Region (2017-2022) & (USD Million)
Table 117. Middle East & Africa Newcastle Disease Vaccine Revenue by Region (2023-2028) & (USD Million)
Table 118. Middle East & Africa Newcastle Disease Vaccine Sales by Type (2017-2022) & (M Doses)
Table 119. Middle East & Africa Newcastle Disease Vaccine Sales by Type (2023-2028) & (M Doses)
Table 120. Middle East & Africa Newcastle Disease Vaccine Sales by Application (2017-2022) & (M Doses)
Table 121. Middle East & Africa Newcastle Disease Vaccine Sales by Application (2023-2028) & (M Doses)
Table 122. Newcastle Disease Vaccine Raw Material
Table 123. Key Manufacturers of Newcastle Disease Vaccine Raw Materials
Table 124. Direct Channel Pros & Cons
Table 125. Indirect Channel Pros & Cons
Table 126. Newcastle Disease Vaccine Typical Distributors
Table 127. Newcastle Disease Vaccine Typical Customers
List of Figures
Figure 1. Newcastle Disease Vaccine Picture
Figure 2. Global Newcastle Disease Vaccine Revenue Market Share by Type in 2021
Figure 3. Live Vaccines
Figure 4. Killed Vaccines
Figure 5. Global Newcastle Disease Vaccine Revenue Market Share by Application in 2021
Figure 6. Chicken
Figure 7. Duck & Goose
Figure 8. Other
Figure 9. Global Newcastle Disease Vaccine Revenue, (USD Million) & (M Doses): 2017 & 2021 & 2028
Figure 10. Global Newcastle Disease Vaccine Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Newcastle Disease Vaccine Sales (2017-2028) & (M Doses)
Figure 12. Global Newcastle Disease Vaccine Price (2017-2028) & (USD/K Doses)
Figure 13. Global Newcastle Disease Vaccine Production Capacity (2017-2028) & (M Doses)
Figure 14. Global Newcastle Disease Vaccine Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Newcastle Disease Vaccine Market Drivers
Figure 16. Newcastle Disease Vaccine Market Restraints
Figure 17. Newcastle Disease Vaccine Market Trends
Figure 18. Global Newcastle Disease Vaccine Sales Market Share by Manufacturer in 2021
Figure 19. Global Newcastle Disease Vaccine Revenue Market Share by Manufacturer in 2021
Figure 20. Newcastle Disease Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Newcastle Disease Vaccine Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Newcastle Disease Vaccine Sales Market Share by Region (2017-2028)
Figure 24. Global Newcastle Disease Vaccine Revenue Market Share by Region (2017-2028)
Figure 25. North America Newcastle Disease Vaccine Revenue (2017-2028) & (USD Million)
Figure 26. Europe Newcastle Disease Vaccine Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Newcastle Disease Vaccine Revenue (2017-2028) & (USD Million)
Figure 28. South America Newcastle Disease Vaccine Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Newcastle Disease Vaccine Revenue (2017-2028) & (USD Million)
Figure 30. Global Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 31. Global Newcastle Disease Vaccine Revenue Market Share by Type (2017-2028)
Figure 32. Global Newcastle Disease Vaccine Price by Type (2017-2028) & (USD/K Doses)
Figure 33. Global Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 34. Global Newcastle Disease Vaccine Revenue Market Share by Application (2017-2028)
Figure 35. Global Newcastle Disease Vaccine Price by Application (2017-2028) & (USD/K Doses)
Figure 36. North America Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 37. North America Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 38. North America Newcastle Disease Vaccine Sales Market Share by Country (2017-2028)
Figure 39. North America Newcastle Disease Vaccine Revenue Market Share by Country (2017-2028)
Figure 40. United States Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 44. Europe Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 45. Europe Newcastle Disease Vaccine Sales Market Share by Country (2017-2028)
Figure 46. Europe Newcastle Disease Vaccine Revenue Market Share by Country (2017-2028)
Figure 47. Germany Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Newcastle Disease Vaccine Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Newcastle Disease Vaccine Revenue Market Share by Region (2017-2028)
Figure 56. China Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 63. South America Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 64. South America Newcastle Disease Vaccine Sales Market Share by Country (2017-2028)
Figure 65. South America Newcastle Disease Vaccine Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Newcastle Disease Vaccine Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Newcastle Disease Vaccine Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Newcastle Disease Vaccine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Newcastle Disease Vaccine in 2021
Figure 77. Manufacturing Process Analysis of Newcastle Disease Vaccine
Figure 78. Newcastle Disease Vaccine Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
